David Gionco, Chief Accounting Officer at STEMLINE THERAPEUTICS INC (STML), sold 3,217 shares at $4.82 ($15K) on 2016-01-19, disclosed to the SEC on 2016-01-21.
Open-market sale of $15k STML by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.82 | 3,171 | $15K | 98.6% |
| 2 | $4.69 | 46 | $216 | 1.4% |
| Total | $4.82 avg | 3,217 | $15K | 100% |
| Filing → |
| STML | SELL | 2020-03-13 | $69K | — | Filing → |
| STML | SELL | 2020-02-28 | $118K | — | Filing → |
| STML | SELL | 2020-01-03 | $49K | — | Filing → |